Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Drug-Mediated Shortening of Action Potentials in LQTS2 Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.

Duncan G, Firth K, George V, Hoang MD, Staniforth A, Smith G, Denning C.

Stem Cells Dev. 2017 Dec 1;26(23):1695-1705. doi: 10.1089/scd.2017.0172. Epub 2017 Oct 9.

2.

Automated Electrophysiological and Pharmacological Evaluation of Human Pluripotent Stem Cell-Derived Cardiomyocytes.

Rajamohan D, Kalra S, Duc Hoang M, George V, Staniforth A, Russell H, Yang X, Denning C.

Stem Cells Dev. 2016 Mar 15;25(6):439-52. doi: 10.1089/scd.2015.0253. Epub 2016 Feb 23.

3.

Catheter ablation of atrial fibrillation in patients with heart failure: impact of maintaining sinus rhythm on heart failure status and long-term rates of stroke and death.

Ullah W, Ling LH, Prabhu S, Lee G, Kistler P, Finlay MC, Earley MJ, Sporton S, Bashir Y, Betts TR, Rajappan K, Thomas G, Duncan E, Staniforth A, Mann I, Chow A, Lambiase P, Schilling RJ, Hunter RJ.

Europace. 2016 May;18(5):679-86. doi: 10.1093/europace/euv440. Epub 2016 Feb 3.

PMID:
26843584
4.

The psychosocial outcomes of anoxic brain injury following cardiac arrest.

Wilson M, Staniforth A, Till R, das Nair R, Vesey P.

Resuscitation. 2014 Jun;85(6):795-800. doi: 10.1016/j.resuscitation.2014.02.008. Epub 2014 Feb 19.

PMID:
24560827
5.

Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes.

Matsa E, Dixon JE, Medway C, Georgiou O, Patel MJ, Morgan K, Kemp PJ, Staniforth A, Mellor I, Denning C.

Eur Heart J. 2014 Apr;35(16):1078-87. doi: 10.1093/eurheartj/eht067. Epub 2013 Mar 6.

6.

Maintenance of sinus rhythm with an ablation strategy in patients with atrial fibrillation is associated with a lower risk of stroke and death.

Hunter RJ, McCready J, Diab I, Page SP, Finlay M, Richmond L, French A, Earley MJ, Sporton S, Jones M, Joseph JP, Bashir Y, Betts TR, Thomas G, Staniforth A, Lee G, Kistler P, Rajappan K, Chow A, Schilling RJ.

Heart. 2012 Jan;98(1):48-53. doi: 10.1136/heartjnl-2011-300720. Epub 2011 Sep 19.

PMID:
21930724
7.

Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation.

Matsa E, Rajamohan D, Dick E, Young L, Mellor I, Staniforth A, Denning C.

Eur Heart J. 2011 Apr;32(8):952-62. doi: 10.1093/eurheartj/ehr073. Epub 2011 Mar 2.

8.

Two new protocols to enhance the production and isolation of human induced pluripotent stem cell lines.

Dick E, Matsa E, Bispham J, Reza M, Guglieri M, Staniforth A, Watson S, Kumari R, Lochm├╝ller H, Young L, Darling D, Denning C.

Stem Cell Res. 2011 Mar;6(2):158-67. doi: 10.1016/j.scr.2010.10.002. Epub 2010 Nov 20.

9.

Device implantation using a novel endovascular subclavian vein puncture employing a combined axillo-femoral approach.

Staniforth AD, Harcombe AA.

Europace. 2011 Feb;13(2):288-9. doi: 10.1093/europace/euq312. Epub 2010 Sep 27. No abstract available.

PMID:
20876276
10.

Hypercalcaemia and a Brugada-like ECG: An independent risk factor for fatal arrhythmias.

Zeb M, McKenzie DB, Naheed B, Gazis T, Morgan JM, Staniforth AD.

Resuscitation. 2010 Aug;81(8):1048-50. doi: 10.1016/j.resuscitation.2010.04.025. Epub 2010 Jun 2. No abstract available.

PMID:
20605668
11.

Reuse of occluded veins during permanent pacemaker lead extraction: a new indication for femoral lead extraction.

Staniforth AD, Schilling RJ.

Indian Pacing Electrophysiol J. 2002 Oct 1;2(4):97-103.

12.

Catheter ablation of permanent atrial fibrillation: medium term results.

Earley MJ, Abrams DJ, Staniforth AD, Sporton SC, Schilling RJ.

Heart. 2006 Feb;92(2):233-8. Epub 2005 Aug 23.

13.

Ventricular arrhythmia, Cheyne-Stokes respiration, and death: observations from patients with defibrillators.

Staniforth AD, Sporton SC, Early MJ, Wedzicha JA, Nathan AW, Schilling RJ.

Heart. 2005 Nov;91(11):1418-22. Epub 2005 Apr 6.

14.

Is there a sex bias in implantable cardioverter-defibrillator referral and prescription?

Staniforth AD, Sporton SC, Robinson NM, Cooper J, Earley MJ, Nathan AW, Schilling RJ.

Heart. 2004 Aug;90(8):937-8. No abstract available.

15.

Contemporary management of chronic stable angina.

Staniforth AD.

Drugs Aging. 2001;18(2):109-21. Review.

PMID:
11346125
16.

Cognitive impairment in heart failure with Cheyne-Stokes respiration.

Staniforth AD, Kinnear WJ, Cowley AJ.

Heart. 2001 Jan;85(1):18-22.

17.

"Value" of improved treadmill exercise capacity: lessons from a study of rate responsive pacing.

Staniforth AD, Andrews R, Harrison M, Perry A, Cowley AJ.

Heart. 1998 Oct;80(4):383-6.

18.

Effect of oxygen on sleep quality, cognitive function and sympathetic activity in patients with chronic heart failure and Cheyne-Stokes respiration.

Staniforth AD, Kinnear WJ, Starling R, Hetmanski DJ, Cowley AJ.

Eur Heart J. 1998 Jun;19(6):922-8.

PMID:
9651717
19.

Nocturnal desaturation in patients with stable heart failure.

Staniforth AD, Kinnear WJ, Starling R, Cowley AJ.

Heart. 1998 Apr;79(4):394-9.

20.

Evidence based treatment of chronic stable angina.

Staniforth AD.

Int J Cardiol. 1998 Jan 5;63(1):21-5. Review. No abstract available.

PMID:
9482141
21.

High Mn2+ sensitivity of vesicular galactosyltransferase in thymus and mammary gland.

Djaballah H, Staniforth AD, Ward S, Kuhn NJ.

Biochem Soc Trans. 1991 Apr;19(2):235S. No abstract available.

PMID:
1909661
22.

Subjective assessment of liquid volumes by humans during swallowing.

Speirs RL, Staniforth A, Sittampalam G.

Arch Oral Biol. 1988;33(10):701-6.

PMID:
3252772

Supplemental Content

Loading ...
Support Center